Malaria: Difference between revisions
From WikiDemocracy
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 187: | Line 187: | ||
[https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000398 by The malERA Consultative Group on Vaccines 25/1/11 PLOS Medicine] | [https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000398 by The malERA Consultative Group on Vaccines 25/1/11 PLOS Medicine] | ||
Vaccines could be a crucial component of efforts to eradicate malaria. Current attempts to develop malaria vaccines are primarily focused on Plasmodium falciparum and are directed towards reducing morbidity and mortality. Continued support for these efforts is essential, but if malaria vaccines are to be used as part of a repertoire of tools for elimination or eradication of malaria, they will need to have an impact on malaria transmission. | Vaccines could be a crucial component of efforts to eradicate malaria. Current attempts to develop malaria vaccines are primarily focused on Plasmodium falciparum and are directed towards reducing morbidity and mortality. Continued support for these efforts is essential, but if malaria vaccines are to be used as part of a repertoire of tools for elimination or eradication of malaria, they will need to have an impact on malaria transmission. | ||
=====Promising malaria vaccine to be tested in first large field trial===== | |||
[https://www.nature.com/articles/d41586-019-01232-4 by Declan Butler 16/4/19 nature] | |||
A malaria vaccine that can provide up to 100% protection against the disease will be tested in a large clinical trial for the first time, to study its efficacy under real-world conditions. | |||
